Inventor
HEYMAN RICHARD A
US23 patents
⚠️ This page may combine multiple inventors who share the name “HEYMAN RICHARD A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIGAND PHARM INC
13 patentsUS6028052AFeb 22, 2000
Treating NIDDM with RXR agonists
LIGAND PHARM INC49 citations95
US5972881AOct 26, 1999
Treating NIDDM with RXR agonists
LIGAND PHARM INC32 citations95
US5780676AJul 14, 1998
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
LIGAND PHARM INC81 citations95
US5962731AOct 5, 1999
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
LIGAND PHARM INC30 citations92
US6545049B1Apr 8, 2003
Dimer-selective RXR modulators and methods for their use
LIGAND PHARM INC22 citations89
US6043279AMar 28, 2000
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
LIGAND PHARM INC16 citations84
US6320074B1Nov 20, 2001
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
LIGAND PHARM INC18 citations81
US6228862B1May 8, 2001
Treating NIDDM with RXR agonists
LIGAND PHARM INC11 citations81
US6521633B2Feb 18, 2003
Treating NIDDM with RXR agonists
LIGAND PHARM INC9 citations73
US6316404B1Nov 13, 2001
Treating NIDDM with RXR agonists
LIGAND PHARM INC9 citations73
US6610883B1Aug 26, 2003
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
LIGAND PHARM INC9 citations70
US7056954B2Jun 6, 2006
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
LIGAND PHARM INC3 citations62
US6992108B1Jan 31, 2006
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
LIGAND PHARM INC0 citations51
SALK INST FOR BIOLOGICAL STUDI
8 patentsUS6096787AAug 1, 2000
Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
SALK INST FOR BIOLOGICAL STUDI66 citations94
US5668175ASep 16, 1997
Use of selective ligands for treatment of disease states responsive to steroid or steroid-like retinoids
SALK INST FOR BIOLOGICAL STUDI76 citations94
US6506917B1Jan 14, 2003
Compounds and compositions useful for modulation of processes mediated by RXR
SALK INST FOR BIOLOGICAL STUDI18 citations92
US5968989AOct 19, 1999
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
SALK INST FOR BIOLOGICAL STUDI17 citations92
US5602009AFeb 11, 1997
Dominant negative chimeras of the steroid/thyroid superfamily of receptors
SALK INST FOR BIOLOGICAL STUDI25 citations92
US5990163ANov 23, 1999
Selective modulation of processes mediated by retinoid X receptors, and compounds useful therefor
SALK INST FOR BIOLOGICAL STUDI51 citations90
US5932622AAug 3, 1999
Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid
SALK INST FOR BIOLOGICAL STUDI14 citations73
US6576676B1Jun 10, 2003
Means for the modulation of processes mediated by retinold receptors and compounds useful therefor
SALK INST FOR BIOLOGICAL STUDI4 citations62